Supplements

The pooled prevalence of moderate-to-high risk of obstructive sleep apnea (OSA) in the Chilean population is 25%

A systematic review and meta-analysis of 15 studies involving 13,157 participants found that the pooled prevalence of moderate-to-high risk of OSA (defined by STOP-Bang score >3) in Chile is 25% (95% CI: 16-34%). The most frequently reported symptoms were snoring, excessive daytime sleepiness, and witnessed apneas. The findings are based mainly on screening questionnaires, with only three studies using respiratory polygraphy.

1 min readUpdated Aug 14, 20260 RCTs1 Meta-analysesView structured evidence →
Evidence Score47/100
Human RCT☆☆☆☆☆
Meta-analysis★★★☆☆
Mechanism★★★★★
Safety★★★★
Confidencelow

This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.

The pooled prevalence of moderate-to-high risk of obstructive sleep apnea (OSA) in the Chilean population is 25% The current body of evidence comprises 1 study and 1 meta-analysis. EvidenceHub rates the overall confidence at 47/100 (low).

The Claim

The pooled prevalence of moderate-to-high risk of obstructive sleep apnea (OSA) in the Chilean population is 25%

This conclusion is most relevant to: Chilean population (general population samples from 15 studies).

What the Research Shows

The conclusion draws on 1 linked study. Highlights from the cited literature:

  • Epidemiology of Obstructive Sleep Apnea in Chile: A Systematic Review and Meta-Analysis. (Revista medica de Chile, 2026) —

How It Works

The proposed biological pathway:

  • Systematic search across seven databases for studies on OSA prevalence/risk in Chile
  • Screening and inclusion of 15 studies with 13,157 participants
  • Data extraction on OSA risk using various tools (STOP-Bang, Epworth, Berlin, etc.)
  • Meta-analysis with random-effects model to pool prevalence estimates
  • Result: 25% pooled prevalence of moderate-to-high OSA risk

Who Might Benefit

Evidence fit by population:

  • Chilean population (general population samples from 15 studies)

Limitations & Caveats

Important context when interpreting this evidence:

  • Only three studies used objective diagnostic methods (respiratory polygraphy); most relied on screening questionnaires, which may overestimate or misclassify OSA risk
  • High heterogeneity (I²=98.4%) across studies, indicating variability in populations and methods

Frequently Asked Questions

What is the prevalence of obstructive sleep apnea risk in Chile?

The pooled prevalence of moderate-to-high risk of OSA (STOP-Bang >3) is 25% (95% CI: 16-34%) based on a meta-analysis of 15 studies.

What tools were used to assess OSA risk in the Chilean studies?

The most frequently used tools were the STOP-Bang questionnaire and the Epworth Sleepiness Scale. The Berlin Questionnaire and sleep quality indices were used less often. Only three studies used respiratory polygraphy.

What are the common symptoms of OSA in the Chilean population?

The most frequently reported symptoms were snoring, excessive daytime sleepiness, and witnessed apneas.

Why is the prevalence estimate based on screening questionnaires considered limited?

Screening questionnaires like STOP-Bang assess risk rather than confirm diagnosis, and only three studies used objective diagnostic methods (respiratory polygraphy), so the true prevalence of OSA may differ.

References

  1. 1.Vasconcello-Castillo L, Torres-Castro R, Otto-Yáñez M, Albertini CS, Solis-Navarro I, Cisternas A, Torres ME, Araos DZ, Vera-Uribe R. “Epidemiology of Obstructive Sleep Apnea in Chile: A Systematic Review and Meta-Analysis..” Revista medica de Chile, 2026. PMID: 42585438 DOI: 10.4067/s0034-98872026000600922
Disclaimer: This article is auto-generated from structured research data for educational purposes only and is not medical advice. Evidence scores reflect the quality and quantity of available research, not clinical recommendations. Always consult a healthcare professional before starting any supplement or intervention.